The drug lost its patent exclusivity in India in late March, triggering a host of generic, or copycat, versions of the drug, launched at cheaper (50-90% lower) costs
In a phase 2, randomized, double-blind, placebo-controlled trial (NCT05669599) of adults with obesity (with and without type 2 diabetes), once-monthly MariTide produced dose-dependent reductions in body weight of up to 16% at 52 weeks, compared with approximately 2% to 3% with placebo
This includes an InBody scan to assess your body composition, a review of your medical history, and an open discussion about your current health and long-term goals
13 explicitly include coverage for weight management under fee-for-service
If you want a more guided next step, you can take the free assessment quiz
Technical Specifications: Proper handling and storage protocols are crucial when working with BPC 157 capsules